NIH Guide: Weekly Index for February 28, 2020

Funding Opportunities

• Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)
  (PAR-20-116)
  National Cancer Institute
  Application Receipt Date(s): May 21, 2020; November 19, 2020; May 20, 2021; November 18, 2021
• Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (R35 - Clinical Trial Optional)
  (PAR-20-117)
  National Institute of General Medical Sciences
  Application Receipt Date(s): October 2, 2020; October 4, 2021; October 3, 2022
• National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional)
  (PAR-20-118)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Application Receipt Date(s): July 27, 2020; November 25, 2020; March 25, 2021; July 26, 2021; November 26, 2021; March 25, 2022
• National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U19 Clinical Trial Optional)
  (PAR-20-119)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Drug Abuse
  Application Receipt Date(s): July 27, 2020; November 25, 2020; March 25, 2021; July 26, 2021; November 26, 2021; March 25, 2022 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Alzheimers Disease Sequencing Project Functional Genomics Consortium (U01 Clinical Trial Not Allowed)
  (RFA-AG-21-006)
  National Institute on Aging
  Application Receipt Date(s): July 1, 2020
• National Longitudinal Study of Adolescent to Adult Health (Add Health) Wave 6 (U01 Clinical Trial Not Allowed)
  (RFA-AG-21-008)
  National Institute on Aging
  National Institute on Drug Abuse
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Office of Behavioral and Social Sciences Research
  Office of Disease Prevention
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): May 18, 2020. No late applications will be accepted for this Funding Opportunity Announcement.
• Planning Projects for Clinical Trials on Effects of Sustained Reductions in Caloric Intake and Related Dietary Practices in Younger and Older Persons (U01 Clinical Trial Optional)
  (RFA-AG-21-016)
  National Institute on Aging
  Application Receipt Date(s): October 8, 2020. No late applications will be accepted for this Funding Opportunity Announcement. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Partnerships for the Development of Universal Influenza Vaccines (R21/R33 Clinical Trial Not Allowed)
  (RFA-AI-20-003)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): July 2, 2020
• Multidisciplinary Studies to Improve Understanding of Influenza Transmission (U19 Clinical Trial Optional)
  (RFA-AI-20-008)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): September 10, 2020 All applications s are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed)
  (RFA-AI-20-009)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): May 29, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed)
  (RFA-AI-20-019)
  National Institute of Allergy and Infectious Diseases
  Application Receipt Date(s): June 15, 2020 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Exploring the Roles of Biomolecular Condensates (BMCs) in HIV replication, latency, or pathogenesis in the context of substance use disorders (R21/R33 Clinical Trial Not Allowed)
  (RFA-DA-21-004)
  National Institute on Drug Abuse
  Application Receipt Date(s): July 20, 2020
• Contraceptive Development Research Centers (CDRC) Program (P50 Clinical Trial Optional)
  (RFA-HD-21-011)
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  Application Receipt Date(s): January 6, 2021 All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
• Limited Competition: Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 Clinical Trial Not Allowed)
  (RFA-MD-20-007)
  National Institute on Minority Health and Health Disparities
  Application Receipt Date(s): ?May 5, 2020 No late applications will be accepted for this Funding Opportunity Announcement.
• BRAIN Initiative: Standards to Define Experiments Related to the BRAIN Initiative (R01 Clinical Trial Not Allowed)
  (RFA-MH-20-128)
  National Institute of Mental Health
  National Institute on Alcohol Abuse and Alcoholism
  National Institute on Aging
  National Institute on Drug Abuse
  National Institute on Deafness and Other Communication Disorders
  National Eye Institute
  Eunice Kennedy Shriver National Institute of Child Health and Human Development
  National Institute of Neurological Disorders and Stroke
  National Center for Complementary and Integrative Health
  National Institute of Biomedical Imaging and Bioengineering
  Office of Behavioral and Social Sciences Research
  Application Receipt Date(s): September 3, 2020 and September 2, 2021 No late applications will be accepted for this Funding Opportunity Announcement.